Clinical trials
Chronic Limb-Threatening Ischemia trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 6 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Unknown status | 7 |
| Terminated | 4 |
| Active, not recruiting | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Hospital Erlangen | 3 |
| Cagent Vascular LLC | 2 |
| GWT-TUD GmbH | 2 |
| Pluristem Ltd. | 2 |
| Spectranetics Corporation | 2 |
| Apceth GmbH & Co. KG | 1 |
| Asklepios Kliniken Hamburg GmbH | 1 |
| C. R. Bard | 1 |
| Cardiovascular and Interventional Radiological Society of Europe | 1 |
| Cook Group Incorporated | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chronic Limb-Threatening Ischemia | 32 |
| Peripheral Arterial Disease | 17 |
| Peripheral Vascular Diseases | 8 |
| Diabetic Foot | 5 |
| Intermittent Claudication | 5 |
| Diabetes Mellitus, Type 2 | 2 |
| Acute Coronary Syndrome | 1 |
| Arterial Occlusive Diseases | 1 |
| Bites and Stings | 1 |
| Cardiovascular Diseases | 1 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.